Industry Update

  • SEC Announces National Compliance Outreach Seminar for Investment Companies and Investment Advisers

Litigation

  • United States Pursues False Claims Act Suit Against Private Equity Firm for Portfolio Company’s Alleged Prescription Kickback Scheme

This communication, which we believe may be of interest to our clients and friends of the firm, is for general information only. It is not a full analysis of the matters presented and should not be relied upon as legal advice. This may be considered attorney advertising in some jurisdictions. Please refer to the firm's privacy notice for further details.